Next Article in Journal
Atherogenic Lipoprotein Burden, Metabolic Stress and Immune Activation Associated with Coronary Atherosclerosis in Patients with Psoriasis
Previous Article in Journal
The Plasma Glycome Differences Between Women with PCOS and Healthy Controls
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJMS
Volume 27
Issue 5
10.3390/ijms27052351
ijms-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Correction to Int. J. Mol. Sci. 2020, 21(23), 9267.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Dal Monte et al. A Topical Formulation of Melatoninergic Compounds Exerts Strong Hypotensive and Neuroprotective Effects in a Rat Model of Hypertensive Glaucoma. Int. J. Mol. Sci. 2020, 21, 9267

by
Massimo Dal Monte
1,*,
Maurizio Cammalleri
1,
Rosario Amato
1,
Salvatore Pezzino
2,
Roberta Corsaro
2,
Paola Bagnoli
1 and
Dario Rusciano
2
1
Department of Biology, University of Pisa, Via San Zeno, 31, 56127 Pisa, Italy
2
Sooft Research Center c/o, University of Catania, Via Santa Sofia, 89, 95123 Catania, Italy
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2026, 27(5), 2351; https://doi.org/10.3390/ijms27052351
Submission received: 26 February 2026 / Accepted: 28 February 2026 / Published: 3 March 2026
(This article belongs to the Section Bioactives and Nutraceuticals)
Browse Figure
Versions Notes
In the original publication [1], there was a mistake in Figure 7 as published. During the preparation of the manuscript, a draft copy of the figure was inadvertently uploaded instead of the finalized figure intended for publication. The authors apologize for this inconvenience. The corrected Figure 7 appears below. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Dal Monte, M.; Cammalleri, M.; Amato, R.; Pezzino, S.; Corsaro, R.; Bagnoli, P.; Rusciano, D. A Topical Formulation of Melatoninergic Compounds Exerts Strong Hypotensive and Neuroprotective Effects in a Rat Model of Hypertensive Glaucoma. Int. J. Mol. Sci. 2020, 21, 9267. [Google Scholar] [CrossRef] [PubMed]
Ijms 27 02351 g007
Figure 7. Retinal ganglion cell (RGC) density. (A) Representative image of a control flat mount immunostained for the brain-specific homeobox/POU domain protein 3A (Brn3a). (B–H) Representative high-magnification images from the middle retina (sampling location at about 2.5 mm from the optic disc) from control rats (B) or rats that received MCE either untreated (C) or treated with vehicles (D,E), timolol (F), brimonidine (G) or melatonin/agomelatine (H). Scale bars: 1 mm (A) or 150 µm (B–H). Magnification: 4× (A) or 20× (B–H). (I) RGC density based on counting analysis of Brn3a-labeled cells. MCE injection reduced RGC density. Decreased RGC density was unaffected by vehicles, but partially recovered with timolol. After brimonidine or melatonin/agomelatine, RGC density recovered to its control value. Data are shown as box-and-whiskers plots (n = 6 retinas for each experimental group). * p < 0.05 versus control; § p < 0.05 versus the respective vehicle (one-way ANOVA followed by Tukey’s post hoc test). MelAgo—melatonin/agomelatine.
Figure 7. Retinal ganglion cell (RGC) density. (A) Representative image of a control flat mount immunostained for the brain-specific homeobox/POU domain protein 3A (Brn3a). (B–H) Representative high-magnification images from the middle retina (sampling location at about 2.5 mm from the optic disc) from control rats (B) or rats that received MCE either untreated (C) or treated with vehicles (D,E), timolol (F), brimonidine (G) or melatonin/agomelatine (H). Scale bars: 1 mm (A) or 150 µm (B–H). Magnification: 4× (A) or 20× (B–H). (I) RGC density based on counting analysis of Brn3a-labeled cells. MCE injection reduced RGC density. Decreased RGC density was unaffected by vehicles, but partially recovered with timolol. After brimonidine or melatonin/agomelatine, RGC density recovered to its control value. Data are shown as box-and-whiskers plots (n = 6 retinas for each experimental group). * p < 0.05 versus control; § p < 0.05 versus the respective vehicle (one-way ANOVA followed by Tukey’s post hoc test). MelAgo—melatonin/agomelatine.
Ijms 27 02351 g007
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Dal Monte, M.; Cammalleri, M.; Amato, R.; Pezzino, S.; Corsaro, R.; Bagnoli, P.; Rusciano, D. Correction: Dal Monte et al. A Topical Formulation of Melatoninergic Compounds Exerts Strong Hypotensive and Neuroprotective Effects in a Rat Model of Hypertensive Glaucoma. Int. J. Mol. Sci. 2020, 21, 9267. Int. J. Mol. Sci. 2026, 27, 2351. https://doi.org/10.3390/ijms27052351

AMA Style

Dal Monte M, Cammalleri M, Amato R, Pezzino S, Corsaro R, Bagnoli P, Rusciano D. Correction: Dal Monte et al. A Topical Formulation of Melatoninergic Compounds Exerts Strong Hypotensive and Neuroprotective Effects in a Rat Model of Hypertensive Glaucoma. Int. J. Mol. Sci. 2020, 21, 9267. International Journal of Molecular Sciences. 2026; 27(5):2351. https://doi.org/10.3390/ijms27052351

Chicago/Turabian Style

Dal Monte, Massimo, Maurizio Cammalleri, Rosario Amato, Salvatore Pezzino, Roberta Corsaro, Paola Bagnoli, and Dario Rusciano. 2026. "Correction: Dal Monte et al. A Topical Formulation of Melatoninergic Compounds Exerts Strong Hypotensive and Neuroprotective Effects in a Rat Model of Hypertensive Glaucoma. Int. J. Mol. Sci. 2020, 21, 9267" International Journal of Molecular Sciences 27, no. 5: 2351. https://doi.org/10.3390/ijms27052351

APA Style

Dal Monte, M., Cammalleri, M., Amato, R., Pezzino, S., Corsaro, R., Bagnoli, P., & Rusciano, D. (2026). Correction: Dal Monte et al. A Topical Formulation of Melatoninergic Compounds Exerts Strong Hypotensive and Neuroprotective Effects in a Rat Model of Hypertensive Glaucoma. Int. J. Mol. Sci. 2020, 21, 9267. International Journal of Molecular Sciences, 27(5), 2351. https://doi.org/10.3390/ijms27052351

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop